
China Still Go-To Source for New Drugs Despite Tariff Minefield
Pharma companies are facing a political minefield as they go about the business of dealmaking. No matter where they turn, uncertainty and sudden policy shifts are rampant. This comes as China innovation rises and European companies face a dearth of …